These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 21184272)
1. Evaluation of estrogen and progesterone receptors in non-neoplastic breast tissue of women of reproductive age exposed to tamoxifen and raloxifene: a randomized, double-blind study. Rosal MA; da Silva BB Breast Cancer Res Treat; 2011 Feb; 125(3):797-801. PubMed ID: 21184272 [TBL] [Abstract][Full Text] [Related]
2. Effects of raloxifene on normal breast tissue from premenopausal women. da Silva BB; Lopes IM; Gebrim LH Breast Cancer Res Treat; 2006 Jan; 95(2):99-103. PubMed ID: 16205837 [TBL] [Abstract][Full Text] [Related]
3. Expression of Ki-67 and Bcl-2 biomarkers in normal breast tissue from women of reproductive age treated with raloxifene. Lima MA; da Silva BB Arch Gynecol Obstet; 2012 Jan; 285(1):223-7. PubMed ID: 21573987 [TBL] [Abstract][Full Text] [Related]
4. Effects of tamoxifen and raloxifene on normal human endometrial cells in an organotypic in vitro model. Bläuer M; Heinonen PK; Rovio P; Ylikomi T Eur J Pharmacol; 2008 Sep; 592(1-3):13-8. PubMed ID: 18638473 [TBL] [Abstract][Full Text] [Related]
5. A comparative study of the effect of raloxifene and gosereline on uterine leiomyoma volume changes and estrogen receptor, progesterone receptor, bcl-2 and p53 expression immunohistochemically in premenopausal women. Baytur YB; Ozbilgin K; Cilaker S; Lacin S; Kurtul O; Oruc S; Koyuncu FM Eur J Obstet Gynecol Reprod Biol; 2007 Nov; 135(1):94-103. PubMed ID: 16973256 [TBL] [Abstract][Full Text] [Related]
6. Effects of two novel selective estrogen receptor modulators, raloxifene, tamoxifen, and ethinyl estradiol on the uterus, vagina and breast in ovariectomized cynomolgus monkeys (Macaca fascicularis). Sikoski P; Register TC; Lees CJ; Lundeen S; Hutchison J; Brown KH; Cline JM Am J Obstet Gynecol; 2007 Jan; 196(1):75.e1-7. PubMed ID: 17240242 [TBL] [Abstract][Full Text] [Related]
7. [Expression of Bax protein in normal tissue of premenopausal women treated with raloxifene]. Furtado-Veloso AM; Lopes IM; Lopes-Costa PV; Santos LG; Silva BB Rev Bras Ginecol Obstet; 2008 Apr; 30(4):177-81. PubMed ID: 19142489 [TBL] [Abstract][Full Text] [Related]
8. Effects of bazedoxifene on BMD and bone turnover in postmenopausal women: 2-yr results of a randomized, double-blind, placebo-, and active-controlled study. Miller PD; Chines AA; Christiansen C; Hoeck HC; Kendler DL; Lewiecki EM; Woodson G; Levine AB; Constantine G; Delmas PD J Bone Miner Res; 2008 Apr; 23(4):525-35. PubMed ID: 18072873 [TBL] [Abstract][Full Text] [Related]
9. Molecular determinants for the tissue specificity of SERMs. Shang Y; Brown M Science; 2002 Mar; 295(5564):2465-8. PubMed ID: 11923541 [TBL] [Abstract][Full Text] [Related]
10. Short-term effects of estrogen, tamoxifen and raloxifene on hemostasis: a randomized-controlled study and review of the literature. Cosman F; Baz-Hecht M; Cushman M; Vardy MD; Cruz JD; Nieves JW; Zion M; Lindsay R Thromb Res; 2005; 116(1):1-13. PubMed ID: 15850603 [TBL] [Abstract][Full Text] [Related]
11. Piloting the effective therapeutic dose of adjunctive selective estrogen receptor modulator treatment in postmenopausal women with schizophrenia. Kulkarni J; Gurvich C; Lee SJ; Gilbert H; Gavrilidis E; de Castella A; Berk M; Dodd S; Fitzgerald PB; Davis SR Psychoneuroendocrinology; 2010 Sep; 35(8):1142-7. PubMed ID: 20171784 [TBL] [Abstract][Full Text] [Related]
12. Effect of raloxifene on salivary sex steroid concentrations in premenopausal women. Chatterton RT; Zujewski J; Mateo ET; Eng-Wong J; Jordan VC J Endocrinol; 2006 Dec; 191(3):599-604. PubMed ID: 17170217 [TBL] [Abstract][Full Text] [Related]
13. The STAR (Study of Tamoxifen and Raloxifene) trial in West Virginia. Jubelirer SJ; Crowell EB W V Med J; 2000; 96(6):602-4. PubMed ID: 11194089 [TBL] [Abstract][Full Text] [Related]
14. Tamoxifen, raloxifene and the prevention of breast cancer. Bentrem DJ; Craig Jordan V Minerva Endocrinol; 2002 Jun; 27(2):127-39. PubMed ID: 11961504 [TBL] [Abstract][Full Text] [Related]
15. Gene expression changes induced by estrogen and selective estrogen receptor modulators in primary-cultured human endometrial cells: signals that distinguish the human carcinogen tamoxifen. Pole JC; Gold LI; Orton T; Huby R; Carmichael PL Toxicology; 2005 Jan; 206(1):91-109. PubMed ID: 15590111 [TBL] [Abstract][Full Text] [Related]
16. The effect of tamoxifen on PCNA expression in fibroadenomas. Bernardes JR; Seixas MT; Lima GR; Marinho LC; Gebrim LH Breast J; 2003; 9(4):302-6. PubMed ID: 12846865 [TBL] [Abstract][Full Text] [Related]
17. The nature of tamoxifen action in the control of female breast cancer. Kodama M; Kodama T In Vivo; 2001; 15(4):319-25. PubMed ID: 11695224 [TBL] [Abstract][Full Text] [Related]
18. Growth response of colon cancer cell lines to selective estrogen receptor modulators. Picariello L; Fiorelli G; Martineti V; Tognarini I; Pampaloni B; Tonelli F; Brandi ML Anticancer Res; 2003; 23(3B):2419-24. PubMed ID: 12894523 [TBL] [Abstract][Full Text] [Related]
19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo. Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645 [TBL] [Abstract][Full Text] [Related]